TMPO and cancer: In addition, survival analysis showed that patients with high TMPO-AS1 expression had shorter overall survival (OS) times across the whole set of various types of cancers (Supplementary Fig. 1e), suggesting that TMPO-AS1 may be a pancancer oncogene.